PD-Rx Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PDRX research report →
Price Chart
About the company
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products.
- CEO
- Robert D. Holsey
- IPO
- 2000
- Employees
- 142
- HQ
- Oklahoma City, OK, US
Get TickerSpark's AI analysis on PDRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.32M
- P/E
- -18.24
- PEG
- -0.18
- P/S
- 0.29
- P/B
- 0.47
- EV/EBITDA
- 2.59
- Div Yield
- 0.00%
- Gross Margin
- 29.61%
- Op Margin
- -2.60%
- Net Margin
- -1.40%
- ROE
- -2.48%
- ROIC
- -4.28%
Latest fiscal year · YoY change
- Revenue
- $18.35M-3.2%
- Gross Profit
- $5.43M-3.4%
- Op Income
- $-477,417
- Net Income
- $-257,523+65.8%
- EPS
- $-0.17+63.0%
- OCF Growth
- +156.6%
- FCF Growth
- +153.4%
- 52W High
- $3.35
- 52W Low
- $2.75
- 50D MA
- $3.20
- 200D MA
- $3.29
- Beta
- 1696040.77
- RSI (14)
- 0
- Avg Volume
- 17
No earnings-call transcripts are available for PDRX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.72M
- Float Shares
- 0
Our PDRX coverage
Recent articles, reports, and earnings notes.
No research on PDRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PDRX report →